Around 2600 people with untreated multiple myeloma and over 23,000 people with ulcerative colitis in England are set to benefit from new treatment options following final draft guidance from the ...

What Does Treatment Failure Mean if You Have Ulcerative Colitis? Alan Moss, MD, chief scientific officer of the Crohns & Colitis Foundation, defines what constitutes ulcerative colitis treatment ...

Emerging therapies for ulcerative colitis treatment, such as Obefazimod (Abivax), Tulisokibart (Merck), Olamkicept (Ferring Pharmaceuticals), Afimkibart (Roche), Icotrokinra (Johnson & ...

Ulcerative colitis is a form of inflammatory bowel disease (IBD), a chronic disease for which there is currently no known cure. The primary sign of the condition is inflammation of the colon and ...

SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness of vedolizumab (Entyvio) versus ustekinumab (Stelara) and of each biologic ...

Share on Pinterest New research is testing the medication tulisokibart in treating ulcerative colitis. Maria Korneeva/Getty Images Ulcerative colitis is a type of inflammatory bowel disease (IBD) and ...

The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis. With ...

A new drug for treating a type of inflammatory bowel disease (IBD) has been given the go-ahead by the Food and Drug Administration. On Friday, the FDA approved Pfizer’s etrasimod, branded as Velsipity ...

Ulcerative Colitis (Japan) 2026, based on a survey of 103 gastroenterologists practicing in Japan, quantify that gap. Nearly three-quarters agree that the long-term risks of uncontrolled disease ...

Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. North America leads the ulcerative ...

Compared with placebo, significantly greater proportions of patients treated with Tremfya achieved clinical remission and endoscopic improvement. HealthDay News — The US Food and Drug Administration ...